Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Leo Pharma patents 3-triazolo-3-deoxy-ingenol derivatives

June 14, 2017

Tarix Orphan's TXA-127 granted orphan drug status in E.U. for epidermolysis bullosa

June 13, 2017

First patient enrolled in DELIVERS trial of Castle Creek Pharmaceuticals' CCP-020

June 6, 2017

FDA grants rare pediatric disease designation to Amicus' SD-101 for epidermolysis bullosa

June 1, 2017

FDA gives rare pediatric disease designation to EB-101 from Abeona

May 31, 2017

FDA awards orphan drug designation to EB-101 from Abeona Therapeutics

May 26, 2017

EMA committee gives positive opinion to brodalumab for plaque psoriasis

May 23, 2017

FDA places CTP-543 phase IIa study on hold

May 18, 2017

Board recommends continuation of Fibrocell Science's phase I/II study of FCX-007

May 9, 2017

BioPharmX's phase IIb study of BPX-011 in acne meets primary endpoint

May 4, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...